FDA Import Refusal 799-3604508-3/10003/1 — Intas Pharmaceuticals Limited
The FDA refused shipment 799-3604508-3/10003/1 from Intas Pharmaceuticals Limited (India) on February 26, 2026. The refused product falls under Drugs and Biologics — BUSPIRONE HCL (TRANQUILIZER). Cited charge: 27 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- February 26, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66MCA09 BUSPIRONE HCL (TRANQUILIZER)
- Charges
- 27